|
| Generic
Available |
|
|
No |

|
|
| Synonyms |
|
|
MSTA |

|
|
| Pharmacological Index |
|
|
Diagnostic Agent |

|
|
| Use |
|
|
Assess the status of cell-mediated immunity |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Stability |
|
|
Refrigerate |

|
|
| Usual Dosage |
|
|
Children and Adults: 0.1 mL intradermally into flexor surface of the forearm;
examine reaction site in 24-48 hours; a positive reaction is greater than or
equal to 1.5 mm diameter induration |

|
|
| Administration |
|
|
Administer intradermally into the flexor surface of the forearm
only |

|
|
| Patient
Information |
|
|
Test must be read between 48 and 72 hours |

|
|
| Nursing
Implications |
|
|
Administer intradermally only into the flexor surface of the forearm
only |

|
|
| Dosage Forms |
|
|
Injection: 1 mL (10 tests) |

|
|
Copyright © 2007 Drugs Area
|